OpenVSafe by OpenVAERS
Search V-safe

BBN-19689-41287

3 vaccinations 1 coded response 28 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
277 / NC
Registered
2022-07-10
Relationship
Child or adolescent in my care
Guardian
2TW-15945-56848
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-10
    Registered in v-safe
  2. 2022-07-10
    Dose 1 — Pfizer-BioNTech
  3. 2022-07-10
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · Site: Redness · None
    Under 3 check-in
  4. 2022-07-11
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-12
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-13
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-14
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-15
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-16
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-17
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-07-24
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-07-31
    Dose 2 — Pfizer-BioNTech
  13. 2022-07-31
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · Site: Pain, Redness · Sleepiness
    Under 3 check-in
  14. 2022-08-02
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Site: Redness · Sleepiness, Loss of appetite
    Under 3 check-in
  15. 2022-08-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Fever · Irritability/crying, Loss of appetite · Be unable to work or attend school
    Under 3 check-in
  16. 2022-08-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-08-05
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-08-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-08-07
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-08-14
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-21
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-08-28
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-09-04
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-09-11
    Health check-in — day 42, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  25. 2022-10-30
    Survey response — 3 months, dose 2, under 3
    MedDRA: Cough, Decreased appetite, Fatigue, Nasal congestion, Respiratory syncytial virus infection, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: RSV with nasal and chest congestion, cough, poor appetite, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  26. 2023-01-29
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  27. 2023-03-08
    Dose 3 — Pfizer-BioNTech
  28. 2023-03-22
    Health check-in — day 14, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  29. 2023-03-29
    Health check-in — day 21, dose 3, under 3
    Feeling: Fair
    Under 3 check-in
  30. 2023-04-05
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  31. 2023-04-19
    Health check-in — day 42, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  32. 2023-06-07
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-10Pfizer-BioNTech No
22022-07-31Pfizer-BioNTech No
32023-03-08Pfizer-BioNTech No

Free text

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-30

Symptoms: RSV with nasal and chest congestion, cough, poor appetite, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDecreased appetite · · ✓
SDFatigue · · ✓
SDNasal congestion · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…